Eli Lilly and Stock Price. Everything You Need To Know About The Eli Lilly and Stock! Eli Lilly and Stock Price. Everything You Need To Know About The Eli Lilly and Stock!


Eli Lilly & Co. is a renowned pharmaceutical company headquartered in Indianapolis, Indiana with a global presence in over 120 countries. With a workforce of 35,000 full-time employees, the firm specializes in the discovery, development, manufacturing, and sale of various human pharmaceutical products.

The company offers a diverse range of products, including diabetes products such as Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity, oncology products like Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio, and immunology products such as Olumiant, Baricitinib, and Taltz. Additionally, it provides neuroscience products like Cymbalta, Emgality, and Zyprexa, and other therapies such as Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo.

As a major player in the pharmaceutical industry, the company caters to various market segments, including wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies.

Investors who want to stay on top of the latest developments can track Eli Lilly & Co.’s share price and market cap. The stock price today, including stocks share price today, is available through various financial news outlets, while premarket trading is also an option for some investors.

In conclusion, Eli Lilly & Co. is a leading pharmaceutical company with a strong presence in the global market. Its diverse range of products and customer-focused approach have helped establish its position as a top player in the industry. Investors interested in the company can track its share price, market cap, and other important metrics to make informed investment decisions.



Eli Lilly and Stock Price. Everything You Need To Know About The Eli Lilly and Stock! performance

  • Employees 35000
  • Company HQ Indianapolis
  • Website https://www.lilly.com/
  • LLY Asset Type Common Stock
  • LLY Market Capitalization 744.3B
  • Earnings Per Share 6.81
  • Dividends Per Share 4.69
  • Dividend Date 2024-06-10
  • Quarterly Earnings Growth 0.664

Company Profile: Eli Lilly and Company is a global pharmaceutical company renowned for its innovative approach to drug development and healthcare solutions. With a rich history spanning over a century, Eli Lilly has become a trusted name in the industry, consistently delivering breakthrough medications in various therapeutic areas. Investing in Eli Lilly: If you are a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, interested in investing in Eli Lilly and Company, Zorion offers a user-friendly platform to seamlessly invest in real US stocks. By leveraging our investment insights and recommendations, you can make informed decisions about your investment portfolio. Access educational materials and resources provided by Zorion to expand your investment knowledge and fully understand the potential opportunities offered by Eli Lilly and Company. Start your investment journey with Zorion and gain exposure to one of the leading global pharmaceutical companies.


Want To Buy Eli Lilly and Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: